Executive Moves Stereotaxis taps investor exec David Fischel as acting CEO Stereotaxis (NASDAQ:STXS) announced a senior management change in a move designed to help re-establish the company’s growth trajectory. February 8, 2017
Feature Stereotaxis sees Japanese reimbursement by year end By Len Zehr After receiving regulatory clearance in Japan of its Niobe Remote Magnetic Navigation system for cardiac ablations last March, Stereotaxis (NASDAQ:STXS) now expects to achieve reimbursement approval by the... September 3, 2013